Florian Halbritter: “Be open and curious, listen, learn, adapt, and improve.”

Scientists off the record: In our summer interview series, St. Anna Children's Cancer Researcher Florian Halbritter shares not only his summer reading shortlist, but also his best advice to bring forward great ideas.

Childhood Leukemia treatment 2022: where we are now and what it takes

Pediatric cancer researchers publish collection of leukemia reviews in top journal “Frontiers in Pediatrics”. According to the authors, new therapies could spare some children a stem cell transplantation.

Gold and Brave against Childhood Cancer

September is Childhood Cancer Awareness Month – a month dedicated to remind us of the dire need to find more and better cures for this devastating disease.

Scientists off the record: “… coincidentally stumbled upon leukemia cells”

St. Anna Childhood Cancer Researcher Michael Dworzak explains which question drives him, what matters in research/life and how to keep cool on hot summer days.

Scientist Sabine Taschner-Mandl off the record: “Be bold and brave – and think outside the box!”

St. Anna Children’s Cancer Researcher Sabine Taschner-Mandl strives to improve the treatment of childhood nerve tumors. We asked what arouses her curiosity and how she spends her summer holidays.

Two St. Anna CCRI projects selected for FWF’s 1000 ideas program

This year’s 1000 ideas program of FWF promotes another two of St. Anna CCRI’s “completely new, daring or particularly original research ideas that lie outside the current scientific understanding”. Florian Halbritter’s new approach aims to integrate machine learning directly into the experimental design and execution of manufacturing specific cell types from stem cells – with the ultimate goal to reprogram even cancer cells. Artem Kalinichenko, who was also awarded a 1000 ideas grant, is targeting abnormal tumor metabolism by identifying cancer-derived metabolites, drugs and drug metabolites that trigger an immune reaction, which could later be exploited for immunotherapy.

Scientist René Geyeregger off the record: His netflix shortlist and what drives him in research

Scientists off the record: St. Anna Children's Cancer Researcher René Geyeregger reveals how he spends his summer vacation, what he is curious about and what drives him in research.

Davide Seruggia earns FWF Stand-Alone funding

To find vulnerabilities of cancers that are driven by MYC, a protein known for its potential to induce tumor growth, is the goal of a new project funded by the Austrian Science Fund FWF. Davide Seruggia from St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and colleagues aim to deactivate this key cancer regulator by targeting components of SAGA, a protein complex tightly linked to MYC. Since pediatric leukemia and neuroblastoma, two of the most common childhood cancers are known to be driven by MYC, establishing new strategies to interrupt its activity in cancer cells is of utmost importance.

Scientists off the record: How Eva König keeps cool on midsummer days

To kick off our new interview series, we asked St. Anna Children's Cancer Researcher Eva König how she copes with midsummer temperatures, what shaped her life as a researcher, and which book should not be missing in her vacation luggage.

World Health Innovation Summit CEO Gareth Presch visits St Anna CCRI

Sharing knowledge about childhood cancer with United Nations´ “Sustainable Development Goals (SDG) Cities”.

Ana Kutschat wins prestigious MSCA Postdoctoral Fellowship

Congratulations to Ana Kutschat on receiving one of the prestigious MSCA Postdoctoral Fellowships!

St. Anna CCRI goes EHA 2022

Happy to welcome our Lithuanian colleagues from the TREL project

St. Anna Children’s Cancer Research Institute focuses on equality

This was the Long Night of Research 2022!

DOC fellowship recipient Elise Sylvander develops safety system for CAR T-cells


EuSARC 2023

When: 18. – 20.05.2022
Where: Van Swieten Saal of the Medical University Vienna; Van-Swieten-Gasse 1a, 1090 Vienna

Presented by: St. Anna Children’s Cancer Research Institute, EuSARC

Read more: